Modalis Therapeutics Corporation (TYO:4883)
Japan · Delayed Price · Currency is JPY 56.00
-3.00 (-5.08%)
Mar 9, 2026, 3:30 PM JST
Modalis Therapeutics Employees
Modalis Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 23 or -62.16% compared to the previous year.
Employees
14
Change (1Y)
-23
Growth (1Y)
-62.16%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
4.90B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 14 | -23 | -62.16% |
| Dec 31, 2023 | 37 | 1 | 2.78% |
| Dec 31, 2022 | 36 | 10 | 38.46% |
| Dec 31, 2021 | 26 | 6 | 30.00% |
| Dec 31, 2020 | 20 | 4 | 25.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nippon Chemiphar | 855 |
| Pharma Foods International | 613 |
| WDB coco | 566 |
| Morishita Jintan | 356 |
| Taiko Pharmaceutical | 214 |
| SymBio Pharmaceuticals | 108 |
| Solasia Pharma K.K. | 23 |
| MedRx | 22 |
Modalis Therapeutics News
- 9 months ago - SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Financial Post